Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species

Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species

An enavogliflozin ophthalmic solution (DWRX2008) is being developed to treat diabetic retinopathy and macular edema. This study evaluated the ocular distribution and plasma pharmacokinetics (PKs) of enavogliflozin in animal species. A sample of [<sup>14</sup>C] enavogliflozin was ocularl...

Full description

Bibliographic Details
Main Authors:	Mingui Jang, Minsung Kang, Eunseok Lee, Dongseong Shin
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Pharmaceuticals
Subjects:	enavogliflozin SGLT2 inhibitor ocular pharmacokinetics diabetic retinopathy diabetic macular edema
Online Access:	https://www.mdpi.com/1424-8247/17/1/111

Similar Items

Pharmacokinetics and Tissue Distribution of Enavogliflozin in Mice and Rats
by: Minyeong Pang, et al.
Published: (2022-06-01)

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
by: Min-Soo Kim, et al.
Published: (2023-03-01)

Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials
by: Young Sang Lyu, et al.
Published: (2024-02-01)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
by: Ines P. Marques, et al.
Published: (2020-05-01)

Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
by: Chewang U Bhutia, et al.
Published: (2023-01-01)

Macular oedema as manifestation of diabetic retinopathy
by: Mukharram M. Bikbov, et al.
Published: (2017-10-01)

Effects of intravitreal bevacizumab injection on the clinical manifestations of nonproliferative diabetic retinopathy in patients with macular edema: a systematic review
by: Touka Banaee, et al.
Published: (2016-04-01)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01)

Oxidative Stress and Its Regulation in Diabetic Retinopathy
by: Cameron D. Haydinger, et al.
Published: (2023-08-01)

Epidemiology of Treated Diabetes Ocular Complications in France 2008–2018—The LANDSCAPE French Nationwide Study
by: Catherine Creuzot-Garcher, et al.
Published: (2022-10-01)

miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies
by: Adriana Solis-Vivanco, et al.
Published: (2022-09-01)

Triamcinolona subtenoniana en el edema macular diabético Subtenon triamcinolone in the diabetic macular edema
by: Eddy Mesa Hernández, et al.
Published: (2009-12-01)

Uso intravítreo de la triamcinolona en el edema macular diabético Use of intravitreous Triamcinolone in cases of diabetic macular edema
by: Juana Elvira Maciques Rodríguez, et al.
Published: (2009-04-01)

Defining Cystoid Macular Degeneration in Diabetic Macular Edema: An OCT-Based Single-center Study
by: Gökçen Yalçın, et al.
Published: (2019-12-01)

Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study
by: Amudha Aravindhan, et al.
Published: (2024-03-01)

Correlation between responses to intravitreal injection of anti-VEGF and diabetic retinopathy extent in diabetic macular edema patients
by: Yue Huang, et al.
Published: (2017-02-01)

High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases
by: Bjorn Kaijun Betzler, et al.
Published: (2020-04-01)

Evaluation of Macular Thickness Changes after Uncomplicated Phacoemulsification Surgery in Healthy Subjects and Diabetic Patients without Retinopathy by Spectral Domain OCT
by: Mikel García Gómez de Segura, et al.
Published: (2022-12-01)

1-Year Fixed-Regimen Bevacizumab Treatment in DME-Vascular Network Image Analysis in Optical Coherence Tomography Angiography Study
by: Magdalena Hunt, et al.
Published: (2022-04-01)

Dietary Intake and Diabetic Retinopathy: A Systematic Review of the Literature
by: Janika Shah, et al.
Published: (2022-11-01)

Guidelines from an expert panel for the management of diabetic macular edema in the Malaysian population
by: Nor Fariza Ngah, et al.
Published: (2023-05-01)

Determination of serum lipid profile in patients with diabetic macular edema that referred to Shahid Beheshti and Ayatollah Rouhani Hospitals, Babol during 2011-2012
by: Seyed Ahmad Rasoulinejad, et al.
Published: (2015-04-01)

Indian Diabetic Retinopathy Image Dataset (IDRiD): A Database for Diabetic Retinopathy Screening Research
by: Prasanna Porwal, et al.
Published: (2018-07-01)

Relationship between Diabetic Nephropathy and Development of Diabetic Macular Edema in Addition to Diabetic Retinopathy
by: Yukihisa Suzuki, et al.
Published: (2023-05-01)

Advances of metabolomics in ocular diseases
by: Jiang Jiaxuan, et al.
Published: (2024-03-01)

Removal of Subfoveal Massive Hard Exudates through an Intentional Macular Hole in Patients with Diabetic Maculopathy: A Report of Three Cases
by: Yukako Iwane, et al.
Published: (2022-08-01)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
by: Yoo-Ri Chung, et al.
Published: (2023-03-01)

Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema
by: Tomoaki Murakami, et al.
Published: (2023-05-01)

Anti-VEGF combined with ocular corticosteroids therapy versus anti-VEGF monotherapy for diabetic macular edema focusing on drugs injection times and confounding factors of pseudophakic eyes: A systematic review and meta-analysis
by: Chengming Chen, et al.
Published: (2023-10-01)

Biomarkers for diabetic retinopathy
by: Maria V. Budzinskaya, et al.
Published: (2020-04-01)

Subthreshold Micropulse Laser Modulates Retinal Neuroinflammatory Biomarkers in Diabetic Macular Edema
by: Luisa Frizziero, et al.
Published: (2021-07-01)

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema
by: Noemi Lois, et al.
Published: (2020-07-01)

Deep Learning Techniques for Diabetic Retinopathy Classification: A Survey
by: Mohammad Z. Atwany, et al.
Published: (2022-01-01)

Reduced serum magnesium is associated with the occurrence of diabetic macular edema in patients with diabetic retinopathy: A retrospective study
by: Xiaoli Xiang, et al.
Published: (2022-09-01)

Ocular syphilis masquerading as refractory retinal diseases
by: Sung Who Park, et al.
Published: (2024-02-01)

Aspirin intake is not associated with diabetic retinopathy and diabetic macular edema: A report from the Fushun diabetic retinopathy cohort study
by: Wei Lin, et al.
Published: (2024-01-01)

The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors
by: Al-Dwairi RA, et al.
Published: (2024-03-01)

Recommendations for diabetic macular edema management by retina specialists and large language model-based artificial intelligence platforms
by: Ayushi Choudhary, et al.
Published: (2024-02-01)

Bibliometric and visualized analysis of diabetic macular edema
by: Jin Wei, et al.
Published: (2024-01-01)

Role of Microaneurysms in the Pathogenesis and Therapy of Diabetic Macular Edema: A Descriptive Review
by: Yoshihiro Takamura, et al.
Published: (2023-02-01)